{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:57:45Z","timestamp":1792623465123,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["100202"],"award-info":[{"award-number":["100202"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["VIDI 917-12-343"],"award-info":[{"award-number":["VIDI 917-12-343"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Molecular Autism"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Tuberous sclerosis complex (TSC) is a rare genetic multisystemic disorder resulting from autosomal dominant mutations in the\n                      <jats:italic>TSC1<\/jats:italic>\n                      or\n                      <jats:italic>TSC2<\/jats:italic>\n                      genes. It is characterised by hyperactivation of the mechanistic target of rapamycin complex 1 (mTORC1) pathway and has severe neurodevelopmental and neurological components including autism, intellectual disability and epilepsy. In human and rodent models, loss of the TSC proteins causes neuronal hyperexcitability and synaptic dysfunction, although the consequences of these changes for the developing central nervous system are currently unclear.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Here we apply multi-electrode array-based assays to study the effects of TSC2 loss on neuronal network activity using autism spectrum disorder (ASD) patient-derived iPSCs. We examine both temporal synchronisation of neuronal bursting and spatial connectivity between electrodes across the network.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We find that ASD patient-derived neurons with a functional loss of\n                      <jats:italic>TSC2<\/jats:italic>\n                      , in addition to possessing neuronal hyperactivity, develop a dysfunctional neuronal network with reduced synchronisation of neuronal bursting and lower spatial connectivity. These deficits of network function are associated with elevated expression of genes for inhibitory GABA signalling and glutamate signalling, indicating a potential abnormality of synaptic inhibitory\u2013excitatory signalling. mTORC1 activity functions within a homeostatic triad of protein kinases, mTOR, AMP-dependent protein Kinase 1 (AMPK) and Unc-51 like Autophagy Activating Kinase 1 (ULK1) that orchestrate the interplay of anabolic cell growth and catabolic autophagy while balancing energy and nutrient homeostasis. The mTOR inhibitor rapamycin suppresses neuronal hyperactivity, but does not increase synchronised network activity, whereas activation of AMPK restores some aspects of network activity. In contrast, the ULK1 activator, LYN-1604, increases the network behaviour, shortens the network burst lengths and reduces the number of uncorrelated spikes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Limitations<\/jats:title>\n                    <jats:p>\n                      Although a robust and consistent phenotype is observed across multiple independent iPSC cultures, the results are based on one patient. There may be more subtle differences between patients with different\n                      <jats:italic>TSC2<\/jats:italic>\n                      mutations or differences of polygenic background within their genomes. This may affect the severity of the network deficit or the pharmacological response between TSC2 patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Our observations suggest that there is a reduction in the network connectivity of the in vitro neuronal network associated with ASD patients with\n                      <jats:italic>TSC2<\/jats:italic>\n                      mutation, which may arise via an excitatory\/inhibitory imbalance due to increased GABA-signalling at inhibitory synapses. This abnormality can be effectively suppressed via activation of ULK1.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13229-020-00391-w","type":"journal-article","created":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T10:03:12Z","timestamp":1603101792000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Pharmacological intervention to restore connectivity deficits of neuronal networks derived from ASD patient iPSC with a TSC2 mutation"],"prefix":"10.1186","volume":"11","author":[{"given":"Mouhamed","family":"Alsaqati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivi M.","family":"Heine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3124-5169","authenticated-orcid":false,"given":"Adrian J.","family":"Harwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,19]]},"reference":[{"key":"391_CR1","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.pedhc.2006.05.004","volume":"212","author":"AK Leung","year":"2007","unstructured":"Leung AK, Robson WL. Tuberous sclerosis complex: a review. J Pediatr Health Care. 2007;212:108\u201314.","journal-title":"J Pediatr Health Care"},{"key":"391_CR2","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1042\/BJ20080281","volume":"4122","author":"J Huang","year":"2008","unstructured":"Huang J, Manning BD. The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. Biochem J. 2008a;4122:179\u201390.","journal-title":"Biochem J"},{"key":"391_CR3","doi-asserted-by":"publisher","first-page":"6107","DOI":"10.1158\/0008-5472.CAN-09-0975","volume":"6915","author":"J Huang","year":"2009","unstructured":"Huang J, Wu S, Wu C-L, Manning BD. Signaling events downstream of mammalian target of rapamycin complex 2 are attenuated in cells and tumors deficient for the tuberous sclerosis complex tumor suppressors. Can Res. 2009;6915:6107\u201314.","journal-title":"Can Res"},{"key":"391_CR4","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.ceb.2005.09.009","volume":"176","author":"DD Sarbassov","year":"2005","unstructured":"Sarbassov DD, Ali SM, Sabatini DM. Growing roles for the mTOR pathway. Curr Opin Cell Biol. 2005;176:596\u2013603.","journal-title":"Curr Opin Cell Biol"},{"key":"391_CR5","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1042\/BJ20080281","volume":"4122","author":"J Huang","year":"2008","unstructured":"Huang J, Manning BD. The TSC1\u2013TSC2 complex: a molecular switchboard controlling cell growth. Biochem J. 2008b;4122:179\u201390.","journal-title":"Biochem J"},{"key":"391_CR6","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/S0140-6736(03)13044-9","volume":"3619366","author":"N El-Hashemite","year":"2003","unstructured":"El-Hashemite N, Zhang H, Henske EP, Kwiatkowski DJ. Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma. Lancet. 2003;3619366:1348\u20139.","journal-title":"Lancet"},{"key":"391_CR7","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1093\/hmg\/11.5.525","volume":"115","author":"DJ Kwiatkowski","year":"2002","unstructured":"Kwiatkowski DJ, Zhang H, Bandura JL, Heiberger KM, Glogauer M, el-Hashemite N, Onda H. A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells. Hum Mol Genet. 2002;115:525\u201334.","journal-title":"Hum Mol Genet"},{"key":"391_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/nrm3025","volume":"121","author":"R Zoncu","year":"2011","unstructured":"Zoncu R, Efeyan A, Sabatini DM. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol. 2011;121:21\u201335.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"391_CR9","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.neuron.2013.03.030","volume":"785","author":"A Normand Elizabeth","year":"2013","unstructured":"Normand Elizabeth A, Crandall Shane R, Thorn Catherine A, Murphy Emily M, Voelcker B, Browning C, Machan Jason T, Moore Christopher I, Connors Barry W, Zervas M. Temporal and mosaic Tsc1 deletion in the developing thalamus disrupts thalamocortical circuitry, neural function, and behavior. Neuron. 2013;785:895\u2013909.","journal-title":"Neuron"},{"key":"391_CR10","doi-asserted-by":"publisher","first-page":"5422","DOI":"10.1523\/JNEUROSCI.0955-08.2008","volume":"2821","author":"L Meikle","year":"2008","unstructured":"Meikle L, Pollizzi K, Egnor A, Kramvis I, Lane H, Sahin M, Kwiatkowski DJ. Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function. J Neurosci Off J Soci Neurosci. 2008;2821:5422\u201332.","journal-title":"J Neurosci Off J Soci Neurosci"},{"key":"391_CR11","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1038\/s41380-018-0018-4","volume":"2311","author":"M Sundberg","year":"2018","unstructured":"Sundberg M, Tochitsky I, Buchholz DE, Winden K, Kujala V, Kapur K, Cataltepe D, Turner D, Han M-J, Woolf CJ, Hatten ME, Sahin M. Purkinje cells derived from TSC patients display hypoexcitability and synaptic deficits associated with reduced FMRP levels and reversed by rapamycin. Mol Psychiatry. 2018;2311:2167\u201383.","journal-title":"Mol Psychiatry"},{"key":"391_CR12","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1038\/nn1566","volume":"812","author":"SF Tavazoie","year":"2005","unstructured":"Tavazoie SF, Alvarez VA, Ridenour DA, Kwiatkowski DJ, Sabatini BL. Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2. Nat Neurosci. 2005;812:1727\u201334.","journal-title":"Nat Neurosci"},{"key":"391_CR13","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/ana.21331","volume":"634","author":"L-H Zeng","year":"2008","unstructured":"Zeng L-H, Xu L, Gutmann DH, Wong M. Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Ann Neurol. 2008;634:444\u201353.","journal-title":"Ann Neurol"},{"key":"391_CR14","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.nbd.2012.10.014","volume":"51","author":"RM Reith","year":"2013","unstructured":"Reith RM, McKenna J, Wu H, Hashmi SS, Cho S-H, Dash PK, Gambello MJ. Loss of Tsc2 in Purkinje cells is associated with autistic-like behavior in a mouse model of tuberous sclerosis complex. Neurobiol Dis. 2013;51:93\u2013103.","journal-title":"Neurobiol Dis"},{"key":"391_CR15","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.nbd.2011.08.024","volume":"451","author":"RP Carson","year":"2012","unstructured":"Carson RP, Van Nielen DL, Winzenburger PA, Ess KC. Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin. Neurobiol Dis. 2012;451:369\u201380.","journal-title":"Neurobiol Dis"},{"key":"391_CR16","doi-asserted-by":"publisher","first-page":"9294","DOI":"10.1523\/JNEUROSCI.0642-19.2019","volume":"3947","author":"KD Winden","year":"2019","unstructured":"Winden KD, Sundberg M, Yang C, Wafa SMA, Dwyer S, Chen P-F, Buttermore ED, Sahin M. Biallelic mutations in TSC2 lead to abnormalities associated with cortical tubers in human iPSC-derived neurons. J Neurosci. 2019;3947:9294\u2013305.","journal-title":"J Neurosci"},{"key":"391_CR17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.stemcr.2018.11.019","volume":"121","author":"AG Nadadhur","year":"2019","unstructured":"Nadadhur AG, Alsaqati M, Gasparotto L, Cornelissen-Steijger P, van Hugte E, Dooves S, Harwood AJ, Heine VM. Neuron-glia interactions increase neuronal phenotypes in tuberous sclerosis complex patient iPSC-derived models. Stem Cell Rep. 2019;121:42\u201356.","journal-title":"Stem Cell Rep"},{"key":"391_CR18","doi-asserted-by":"publisher","first-page":"4071","DOI":"10.1158\/1078-0432.CCR-11-0445","volume":"1712","author":"DM Davies","year":"2011","unstructured":"Davies DM, de Vries PJ, Johnson SR, McCartney DL, Cox JA, Serra AL, Watson PC, Howe CJ, Doyle T, Pointon K, Cross JJ, Tattersfield AE, Kingswood JC, Sampson JR. Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial. Clin Cancer Res. 2011;1712:4071\u201381.","journal-title":"Clin Cancer Res"},{"key":"391_CR19","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ncb2152","volume":"132","author":"J Kim","year":"2011","unstructured":"Kim J, Kundu M, Viollet B, Guan K-L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011;132:132\u201341.","journal-title":"Nat Cell Biol"},{"key":"391_CR20","doi-asserted-by":"publisher","first-page":"737","DOI":"10.4161\/auto.7.7.15491","volume":"77","author":"EA Dunlop","year":"2011","unstructured":"Dunlop EA, Hunt DK, Acosta-Jaquez HA, Fingar DC, Tee AR. ULK1 inhibits mTORC1 signaling, promotes multisite Raptor phosphorylation and hinders substrate binding. Autophagy. 2011;77:737\u201347.","journal-title":"Autophagy"},{"key":"391_CR21","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1681\/ASN.2008111186","volume":"2012","author":"W Lieberthal","year":"2009","unstructured":"Lieberthal W, Levine JS. The role of the mammalian target of rapamycin (mTOR) in renal disease. J Am Soc Nephrol. 2009;2012:2493\u2013502.","journal-title":"J Am Soc Nephrol"},{"key":"391_CR22","first-page":"e13378","volume":"5","author":"X Zheng","year":"2016","unstructured":"Zheng X, Boyer L, Jin M, Kim Y, Fan W, Bardy C, Berggren T, Evans RM, Gage FH, Hunter T. Alleviation of neuronal energy deficiency by mTOR inhibition as a treatment for mitochondria-related neurodegeneration. Life. 2016;5:e13378.","journal-title":"Life"},{"key":"391_CR23","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1126\/science.1196371","volume":"3316016","author":"DF Egan","year":"2011","unstructured":"Egan DF, Shackelford DB, Mihaylova MM, Gelino S, Kohnz RA, Mair W, Vasquez DS, Joshi A, Gwinn DM, Taylor R, Asara JM, Fitzpatrick J, Dillin A, Viollet B, Kundu M, Hansen M, Shaw RJ. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science (New York, NY). 2011;3316016:456\u201361.","journal-title":"Science (New York, NY)"},{"key":"391_CR24","doi-asserted-by":"publisher","first-page":"6491","DOI":"10.1021\/acs.jmedchem.7b01684","volume":"6115","author":"L Zhang","year":"2018","unstructured":"Zhang L, Ouyang L, Guo Y, Zhang J, Liu B. UNC-51-like Kinase 1: from an autophagic initiator to multifunctional drug target. J Med Chem. 2018;6115:6491\u2013500.","journal-title":"J Med Chem"},{"key":"391_CR25","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/mt.2010.314","volume":"194","author":"E Warlich","year":"2011","unstructured":"Warlich E, Kuehle J, Cantz T, Brugman MH, Maetzig T, Galla M, Filipczyk AA, Halle S, Klump H, Sch\u00f6ler HR, Baum C, Schroeder T, Schambach A. Lentiviral vector design and imaging approaches to visualize the early stages of cellular reprogramming. Mol Ther. 2011;194:782\u20139.","journal-title":"Mol Ther"},{"key":"391_CR26","doi-asserted-by":"publisher","first-page":"e0178533","DOI":"10.1371\/journal.pone.0178533","volume":"126","author":"AG Nadadhur","year":"2017","unstructured":"Nadadhur AG, Emperador Melero J, Meijer M, Schut D, Jacobs G, Li KW, Hjorth JJJ, Meredith RM, Toonen RF, Van Kesteren RE, Smit AB, Verhage M, Heine VM. Multi-level characterization of balanced inhibitory-excitatory cortical neuron network derived from human pluripotent stem cells. PLoS ONE. 2017;126:e0178533\u2013e0178533.","journal-title":"PLoS ONE"},{"key":"391_CR27","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"254","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method. Methods. 2001;254:402\u20138.","journal-title":"Methods"},{"key":"391_CR28","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1162\/089976604774201631","volume":"168","author":"RQ Quiroga","year":"2004","unstructured":"Quiroga RQ, Nadasdy Z, Ben-Shaul Y. Unsupervised spike detection and sorting with wavelets and superparamagnetic clustering. Neural Comput. 2004;168:1661\u201387.","journal-title":"Neural Comput"},{"key":"391_CR29","doi-asserted-by":"publisher","first-page":"13810","DOI":"10.1038\/s41598-019-50226-9","volume":"91","author":"W Plumbly","year":"2019","unstructured":"Plumbly W, Brandon N, Deeb TZ, Hall J, Harwood AJ. L-type voltage-gated calcium channel regulation of in vitro human cortical neuronal networks. Sci Rep. 2019;91:13810.","journal-title":"Sci Rep"},{"key":"391_CR30","doi-asserted-by":"publisher","first-page":"26181","DOI":"10.1038\/srep26181","volume":"61","author":"A Odawara","year":"2016","unstructured":"Odawara A, Katoh H, Matsuda N, Suzuki I. Physiological maturation and drug responses of human induced pluripotent stem cell-derived cortical neuronal networks in long-term culture. Sci Rep. 2016;61:26181.","journal-title":"Sci Rep"},{"key":"391_CR31","doi-asserted-by":"publisher","first-page":"7275","DOI":"10.1073\/pnas.86.18.7275","volume":"8618","author":"G Puia","year":"1989","unstructured":"Puia G, Santi MR, Vicini S, Pritchett DB, Seeburg PH, Costa E. Differences in the negative allosteric modulation of gamma-aminobutyric acid receptors elicited by 4\u2019-chlorodiazepam and by a beta-carboline-3-carboxylate ester: a study with natural and reconstituted receptors. Proc Natl Acad Sci USA. 1989;8618:7275\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"391_CR32","doi-asserted-by":"publisher","first-page":"30507","DOI":"10.1038\/srep30507","volume":"6","author":"BP Grone","year":"2016","unstructured":"Grone BP, Maruska KP. Three distinct glutamate decarboxylase genes in vertebrates. Sci Rep. 2016;6:30507\u201330507.","journal-title":"Sci Rep"},{"key":"391_CR33","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/ng.677","volume":"4211","author":"S Endele","year":"2010","unstructured":"Endele S, Rosenberger G, Geider K, Popp B, Tamer C, Stefanova I, Milh M, Kort\u00fcm F, Fritsch A, Pientka FK, Hellenbroich Y, Kalscheuer VM, Kohlhase J, Moog U, Rappold G, Rauch A, Ropers H-H, von Spiczak S, T\u00f6nnies H, Villeneuve N, Villard L, Zabel B, Zenker M, Laube B, Reis A, Wieczorek D, Van Maldergem L, Kutsche K. Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes. Nat Genet. 2010;4211:1021\u20136.","journal-title":"Nat Genet"},{"key":"391_CR34","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nrn.2016.37","volume":"176","author":"JM Henley","year":"2016","unstructured":"Henley JM, Wilkinson KA. Synaptic AMPA receptor composition in development, plasticity and disease. Nat Rev Neurosci. 2016;176:337\u201350.","journal-title":"Nat Rev Neurosci"},{"key":"391_CR35","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.1073\/pnas.83.10.3500","volume":"8310","author":"B Wiedenmann","year":"1986","unstructured":"Wiedenmann B, Franke WW, Kuhn C, Moll R, Gould VE. Synaptophysin: a marker protein for neuroendocrine cells and neoplasms. Proc Natl Acad Sci USA. 1986;8310:3500\u20134.","journal-title":"Proc Natl Acad Sci USA"},{"key":"391_CR36","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1128\/MCB.05430-11","volume":"3114","author":"B Nyfeler","year":"2011","unstructured":"Nyfeler B, Bergman P, Triantafellow E, Wilson CJ, Zhu Y, Radetich B, Finan PM, Klionsky DJ, Murphy LO. Relieving autophagy and 4EBP1 from rapamycin resistance. Mol Cell Biol. 2011;3114:2867\u201376.","journal-title":"Mol Cell Biol"},{"key":"391_CR37","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1039\/C6SC05368H","volume":"84","author":"L Zhang","year":"2017","unstructured":"Zhang L, Fu L, Zhang S, Zhang J, Zhao Y, Zheng Y, He G, Yang S, Ouyang L, Liu B. Discovery of a small molecule targeting ULK1-modulated cell death of triple negative breast cancer in vitro and in vivo. Chem Sci. 2017;84:2687\u2013701.","journal-title":"Chem Sci"},{"key":"391_CR38","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1080\/15548627.2017.1283470","volume":"134","author":"L Ouyang","year":"2017","unstructured":"Ouyang L, Zhang L, Fu L, Liu B. A small-molecule activator induces ULK1-modulating autophagy-associated cell death in triple negative breast cancer. Autophagy. 2017;134:777\u20138.","journal-title":"Autophagy"},{"key":"391_CR39","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.cell.2006.06.055","volume":"1265","author":"K Inoki","year":"2006","unstructured":"Inoki K, Ouyang H, Zhu T, Lindvall C, Wang Y, Zhang X, Yang Q, Bennett C, Harada Y, Stankunas K, Wang CY, He X, MacDougald OA, You M, Williams BO, Guan KL. TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell. 2006;1265:955\u201368.","journal-title":"Cell"},{"key":"391_CR40","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13041-019-0427-6","volume":"121","author":"J-P Zhao","year":"2019","unstructured":"Zhao J-P, Yoshii A. Hyperexcitability of the local cortical circuit in mouse models of tuberous sclerosis complex. Mol Brain. 2019;121:6.","journal-title":"Mol Brain"},{"key":"391_CR41","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.neuron.2013.03.017","volume":"783","author":"HS Bateup","year":"2013","unstructured":"Bateup HS, Johnson CA, Denefrio CL, Saulnier JL, Kornacker K, Sabatini BL. Excitatory\/inhibitory synaptic imbalance leads to hippocampal hyperexcitability in mouse models of tuberous sclerosis. Neuron. 2013;783:510\u201322.","journal-title":"Neuron"},{"key":"391_CR42","doi-asserted-by":"publisher","first-page":"5546","DOI":"10.1523\/JNEUROSCI.5540-06.2007","volume":"2721","author":"L Meikle","year":"2007","unstructured":"Meikle L, Talos DM, Onda H, Pollizzi K, Rotenberg A, Sahin M, Jensen FE, Kwiatkowski DJ. A mouse model of tuberous sclerosis: neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival. J Neurosci. 2007;2721:5546\u201358.","journal-title":"J Neurosci"},{"key":"391_CR43","first-page":"29","volume":"5","author":"J DeFelipe","year":"2011","unstructured":"DeFelipe J. The evolution of the brain, the human nature of cortical circuits, and intellectual creativity. Front Neuroanat. 2011;5:29.","journal-title":"Front Neuroanat"},{"key":"391_CR44","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/ana.21058","volume":"612","author":"Y Wang","year":"2007","unstructured":"Wang Y, Greenwood JS, Calcagnotto ME, Kirsch HE, Barbaro NM, Baraban SC. Neocortical hyperexcitability in a human case of tuberous sclerosis complex and mice lacking neuronal expression of TSC1. Ann Neurol. 2007;612:139\u201352.","journal-title":"Ann Neurol"},{"key":"391_CR45","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.biopsych.2016.09.017","volume":"8110","author":"R Tatti","year":"2017","unstructured":"Tatti R, Haley MS, Swanson OK, Tselha T, Maffei A. Neurophysiology and regulation of the balance between excitation and inhibition in neocortical circuits. Biol Psychiatry. 2017;8110:821\u201331.","journal-title":"Biol Psychiatry"},{"key":"391_CR46","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1177\/38.6.2110586","volume":"386","author":"E Masliah","year":"1990","unstructured":"Masliah E, Terry RD, Alford M, DeTeresa R. Quantitative immunohistochemistry of synaptophysin in human neocortex: an alternative method to estimate density of presynaptic terminals in paraffin sections. J Histochem Cytochem. 1990;386:837\u201344.","journal-title":"J Histochem Cytochem"},{"key":"391_CR47","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.1073\/pnas.0811698106","volume":"10610","author":"RM Koffie","year":"2009","unstructured":"Koffie RM, Meyer-Luehmann M, Hashimoto T, Adams KW, Mielke ML, Garcia-Alloza M, Micheva KD, Smith SJ, Kim ML, Lee VM, Hyman BT, Spires-Jones TL. Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques. Proc Natl Acad Sci USA. 2009;10610:4012\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"391_CR48","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.4161\/15384101.2014.989114","volume":"1418","author":"S Braat","year":"2015","unstructured":"Braat S, Hulst C, Heulens I, De Rubeis S, Mientjes E, Nelson DL, Willemsen R, Bagni C, Van Dam D, De Deyn PP, Kooy RF. The GABAA receptor is an FMRP target with therapeutic potential in fragile X syndrome. Cell Cycle (Georgeton, Tex). 2015;1418:2985\u201395.","journal-title":"Cell Cycle (Georgeton, Tex.)"},{"key":"391_CR49","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1002\/acn3.494","volume":"412","author":"DA Krueger","year":"2017","unstructured":"Krueger DA, Sadhwani A, Byars AW, de Vries PJ, Franz DN, Whittemore VH, Filip-Dhima R, Murray D, Kapur K, Sahin M. Everolimus for treatment of tuberous sclerosis complex-associated neuropsychiatric disorders. Ann Clin Transl Neurol. 2017;412:877\u201387.","journal-title":"Ann Clin Transl Neurol"},{"key":"391_CR50","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13229-019-0311-3","volume":"11","author":"P Martin","year":"2020","unstructured":"Martin P, Wagh V, Reis SA, Erdin S, Beauchamp RL, Shaikh G, Talkowski M, Thiele E, Sheridan SD, Haggarty SJ, Ramesh V. TSC patient-derived isogenic neural progenitor cells reveal altered early neurodevelopmental phenotypes and rapamycin-induced MNK-eIF4E signaling. Mol Autism. 2020;11:2\u20132.","journal-title":"Mol Autism"},{"key":"391_CR51","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.ccr.2006.03.029","volume":"95","author":"Q-W Fan","year":"2006","unstructured":"Fan Q-W, Knight ZA, Goldenberg DD, Yu W, Mostov KE, Stokoe D, Shokat KM, Weiss WA. A dual PI3 kinase\/mTOR inhibitor reveals emergent efficacy in glioma. Cancer Cell. 2006;95:341\u20139.","journal-title":"Cancer Cell"}],"container-title":["Molecular Autism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13229-020-00391-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13229-020-00391-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13229-020-00391-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T20:30:39Z","timestamp":1634589039000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularautism.biomedcentral.com\/articles\/10.1186\/s13229-020-00391-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,19]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["391"],"URL":"https:\/\/doi.org\/10.1186\/s13229-020-00391-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-35221\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-35221\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-35221\/v3","asserted-by":"object"}]},"ISSN":["2040-2392"],"issn-type":[{"value":"2040-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,19]]},"assertion":[{"value":"12 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experiments were exempt from approval of Medical Ethical Toetsingscommissie (METC), Institutional Review Board of the VU medical centre.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"80"}}